Pure Financial Advisors LLC Takes $609,000 Position in Corteva, Inc. $CTVA

Pure Financial Advisors LLC bought a new position in shares of Corteva, Inc. (NYSE:CTVA) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 7,196 shares of the company’s stock, valued at approximately $609,000.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. BlackRock Inc. bought a new stake in Corteva during the second quarter worth about $4,560,180,000. Harris Associates L P raised its stake in shares of Corteva by 168.1% during the 4th quarter. Harris Associates L P now owns 17,026,221 shares of the company’s stock worth $1,141,268,000 after purchasing an additional 10,675,052 shares in the last quarter. Norges Bank acquired a new stake in shares of Corteva in the 4th quarter valued at approximately $504,001,000. Jupiter Topco LLC bought a new position in shares of Corteva in the second quarter valued at $544,246,000. Finally, Bank of America Corp DE acquired a new position in Corteva during the second quarter worth $484,927,000. 81.54% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

CTVA has been the subject of a number of recent analyst reports. Morgan Stanley increased their price target on shares of Corteva from $84.00 to $95.00 and gave the company an “overweight” rating in a research note on Thursday, May 28th. Bank of America raised their target price on shares of Corteva from $90.00 to $96.00 and gave the company a “buy” rating in a research note on Monday, July 20th. BNP Paribas Exane lifted their price target on Corteva from $74.00 to $77.00 in a report on Wednesday, May 6th. Rothschild & Co Redburn raised their price objective on Corteva from $80.00 to $90.00 and gave the company a “neutral” rating in a research report on Wednesday, April 29th. Finally, UBS Group decreased their target price on Corteva from $89.00 to $85.00 and set a “neutral” rating on the stock in a report on Tuesday, August 18th. Fourteen investment analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $91.50.

Corteva Stock Performance

NYSE:CTVA opened at $83.08 on Thursday. The company has a market cap of $55.43 billion, a price-to-earnings ratio of 55.02, a PEG ratio of 2.55 and a beta of 0.57. Corteva, Inc. has a fifty-two week low of $60.53 and a fifty-two week high of $90.97. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.10 and a current ratio of 1.52. The stock has a fifty day moving average price of $82.51 and a 200-day moving average price of $80.45.

Corteva (NYSE:CTVA) last posted its quarterly earnings results on Thursday, July 30th. The company reported $2.30 EPS for the quarter, beating analysts’ consensus estimates of $2.24 by $0.06. The business had revenue of $6.38 billion during the quarter, compared to the consensus estimate of $6.60 billion. Corteva had a return on equity of 10.18% and a net margin of 5.66%.Corteva’s revenue for the quarter was down 1.2% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $2.20 earnings per share. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. As a group, equities analysts anticipate that Corteva, Inc. will post 3.72 EPS for the current fiscal year.

Corteva Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 15th. Shareholders of record on Tuesday, September 1st will be paid a dividend of $0.18 per share. The ex-dividend date is Tuesday, September 1st. This represents a $0.72 annualized dividend and a yield of 0.9%. Corteva’s dividend payout ratio is presently 47.68%.

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.